Methotrexate treatment in cutaneous lupus erythematosus: subcutaneous application is as effective as intravenous administration.
Huber
A
A
Tüting
T
T
Bauer
R
R
Bieber
T
T
Wenzel
J
J
D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008178:Lupus Erythematosus, Cutaneous / Q000188:drug therapy*; D008727:Methotrexate / Q000008:administration & dosage*; D012189:Retrospective Studies; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D008727:Methotrexate